![Connie Matsui](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Connie Matsui
Chairman at
ARTELO BIOSCIENCES, INC.
Net worth: 146 444 $ as of 2026-05-30
Profile
Ms. Connie L. Matsui is a Chairman at Sutro Biopharma, Inc., a Chairman at Artelo Biosciences, Inc., a Chairman at Halozyme Therapeutics, Inc. and a Chairman at Balboa Park Conservancy. Ms. Matsui was previously employed as a National President by Girl Scouts of the USA, an Executive Vice President by Biogen Idec New Ventures, Inc., a Senior Vice President by IDEC Pharmaceuticals Corp., an Executive VP-Knowledge & Innovation Networks by Biogen Idec, Inc., and a President & Chief Executive Officer by The San Diego Foundation. She received her undergraduate degree from Stanford University and an MBA from Stanford University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-04 | 5,000 ( 0.03% ) | 146 150 $ | 2026-05-30 | |
| 2026-02-19 | 210 ( 0.01% ) | 294 $ | 2026-05-30 |
Connie Matsui active positions
| Companies | Position | Start |
|---|---|---|
| ARTELO BIOSCIENCES, INC. | Chairman | 2017-05-01 |
| SUTRO BIOPHARMA, INC. | Chairman | 2019-06-23 |
Former positions of Connie Matsui
| Companies | Position | End |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Chairman | - |
The San Diego Foundation
 The San Diego Foundation Miscellaneous Commercial ServicesCommercial Services Provides information about charitable giving and community needs | Chief Executive Officer | 2019-04-30 |
| BIOGEN INC. | Corporate Officer/Principal | 2008-12-31 |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 2008-12-31 |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Corporate Officer/Principal | 2008-03-30 |
Training of Connie Matsui
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
The San Diego Foundation
The San Diego Foundation Miscellaneous Commercial ServicesCommercial Services Provides information about charitable giving and community needs | Commercial Services |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
Artelo Biosciences, Inc.
 Artelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops endocannabinoid system modulating therapeutics | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes targeted immunotherapies for the treatment of cancer and autoimmune diseases | Health Technology |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Girl Scouts of the USA
 Girl Scouts of the USA Miscellaneous Commercial ServicesCommercial Services Helps to build character and skills for girls | Commercial Services |
Balboa Park Conservancy
 Balboa Park Conservancy Miscellaneous Commercial ServicesCommercial Services Provides advocacy services | Commercial Services |
- Stock Market
- Insiders
- Connie Matsui
